# A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

> **NCT02546375** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 87 (actual)

## Conditions studied

- Chronic Myeloid Leukaemia

## Interventions

- **DRUG:** Bosutinib

## Key facts

- **NCT ID:** NCT02546375
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-15
- **Primary completion:** 2017-01-16
- **Final completion:** 2017-01-16
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02546375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02546375, "A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02546375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*